![Weng Tao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Weng Tao is the founder of Neurotech Pharmaceuticals, Inc. which was founded in 1995.
She held the titles of CSO and VP-Research & Development from 2011 to 2013.
Dr. Tao also worked as a Director-Cell Research at CytoTherapuetics, Inc. and as a Principal at Regeneron Pharmaceuticals, Inc. Dr. Tao holds a doctorate degree from both the University of Connecticut and Capital Medical University.
| Bedrijven | Functie | Einde |
|---|---|---|
CytoTherapuetics, Inc.
 CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Corporate Officer/Principal | - |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 5 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Health Technology |
CytoTherapuetics, Inc.
CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Finance |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capital Medical University
 Capital Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
